Search This Blog

1

Labels

Cancer (150) Breast (38) Study (38) Health (32) Patients (31) Treatment (27) Could (23) Therapy (19) Research (17) Against (12) Blood (11) Disease (11) linked (11) Diabetes (10) Early (10) Prevent (10) Survival (10) Treatments (7) higher (7) surgery (7) Might (6) Prostate (6) Tumors (6) During (5) Effects (5) Growth (5) Chemotherapy (4) Drinking (4) Prevention (4) Obama (3) Obesity (3) Without (3) associated (3) Experts (2) Important (2) Infection (2) About (1) Analysis (1) Causes (1) Eliminate (1) stroke (1)

AD

Saturday, April 26, 2014

Florida overcomes GOP barriers to enroll uninsured

MIAMI (AP) — Florida's Republican leaders have fought the Affordable Care Act at every turn, banning navigators from county health departments, offering no state dollars to boost outreach efforts to 3.5 million uninsured and leading the fight to repeal the law. Yet the state has emerged as a tale of what went right with President Barack Obama's health care overhaul.

More than 440,000 Florida residents had been enrolled through the federal marketplace through the end of February.

Florida's success is due partly to infrastructure created in the swing state by Democratic-affiliated groups during the last three presidential elections, along with continued investment by the Obama administration and nonprofit advocacy groups in the diverse state that will be competitive in November's midterm election.

___

Kennedy can be followed on Twitter https://twitter.com/kkennedyAP


View the original article here

Friday, April 25, 2014

Treasury says Lew leaves hospital after surgery

WASHINGTON (Reuters) - U.S. Treasury Secretary Jack Lew was discharged from a hospital on Wednesday following a surgery to treat a benign enlarged prostate, a Treasury spokesperson said.

"(Lew) is now at home recuperating from his surgical procedure yesterday," Treasury spokeswoman Natalie Wyeth Earnest said in a statement. "He is in good spirits, talking with staff, and looks forward to being back in the office next week."

The spokeswoman had said on Tuesday the surgery went well but that Lew's doctor decided to keep him in the hospital overnight because he was running a low fever.

Lew, 58, was sworn in as Treasury secretary in February 2013 after serving as President Barack Obama's chief of staff.

(Reporting by Timothy Ahmann; Editing by Chizu Nomiyama)


View the original article here

Thursday, April 24, 2014

Doctors Really Do Raise Your Blood Pressure

WEDNESDAY, March 26, 2014 (HealthDay News) -- Patients' blood pressure readings are notably higher when they're taken by a doctor than by a nurse, a new study finds.

This link between doctors and higher blood pressure readings is known as the "white coat effect," and is believed to be the result of patients being more nervous when examined by a physician.

This effect has been noted in a number of previous studies, but this new paper is the first to confirm it, according to the study authors.

The investigators analyzed data from more than 1,000 people who had blood pressure readings taken by both doctors and nurses during the same visit. The readings taken by doctors were significantly higher than those taken by nurses, the study authors found.

The findings, published in the current issue of the British Journal of General Practice, should lead to changes in the way blood pressure readings are taken, according to lead author Dr. Christopher Clark, of the University of Exeter Medical School, in England.

"Doctors should continue to measure blood pressure as part of the assessment of an ill patient or a routine check-up, but not where clinical decisions on blood pressure treatment depend on the outcome," Clark said in a university news release.

"The difference we noted is enough to tip some patients over the threshold for treatment for high blood pressure, and unnecessary medication can lead to unwanted side-effects," he said.

"Some patients may be erroneously asked to continue to monitor their own blood pressure at home, which can build anxiety. These inappropriate measures could all be avoided by the simple measure of someone other than a doctor taking the blood pressure recording," Clark added.

He suggested that researchers "should also think carefully about how to account for this effect in studies that compare treatment by doctors and nurses. Some studies have concluded that nurses are better at treating [high blood pressure], when in fact those findings could be down to this recording bias."

More information

The U.S. National Heart, Lung, and Blood Institute explains how to prevent high blood pressure.

Copyright c 2014?HealthDay. All rights reserved.


View the original article here

Tuesday, April 22, 2014

Virginia lawmakers recess without Medicaid, budget deal

By Gary Robertson

RICHMOND, Virginia (Reuters) - Virginia's legislature has recessed without reaching agreement with Democratic Governor Terry McAuliffe over a budget or Medicaid expansion.

McAuliffe, a former Democratic Party fundraiser, and the Republican-dominated House of Delegates are deadlocked over a two-year pilot expansion of Medicaid, the federal healthcare program for the poor the governor has proposed.

House lawmakers meeting in a two-day special session defeated McAuliffe's proposed $96 billion two-year budget late on Tuesday. The House then passed its own version of the budget without Medicaid expansion, seen as a priority for the governor, before adjourning.

The Democratic-controlled state Senate will reconvene April 7 to take up the budget fight anew. A budget must be approved by June 30 or risk state operations starting to shut down.

Republicans are asking McAuliffe to deal with the budget and Medicaid in separate sessions.

"We would be more than happy to debate Medicaid in a special session," said Kirk Cox, Republican House majority leader. "I think is afraid he loses all his leverage without the budget."

McAuliffe, who made Medicaid expansion the centerpiece of his gubernatorial campaign last year, has not responded to the rebuff.

But he has said that accepting $2 billion in federal funds to expand Medicaid under the Affordable Care Act would release money that could be used to create jobs, raise state salaries, bolster pensions and implement health reforms.

(Editing by Ian Simpson and Gunna Dickson)


View the original article here

Monday, April 21, 2014

One in 25 patients battling hospital-acquired infections: CDC

By Gene Emery

NEW YORK (Reuters Health) - On any given day, one in 25 hospitalized patients - 4 percent - is battling an infection picked up in a hospital or other healthcare facility, according to a new survey by the Centers for Disease Control and Prevention (CDC).

That translates to more than 600,000 hospital patients each year. Roughly 74,000 of them have to fight more than one hospital-acquired infection, researchers found.

About half of those infections were either linked to a device attached to the patient, like a catheter or ventilator, or occurred after a surgical procedure at the site of the surgery.

Previous estimates had pegged the annual number of infections at 2.1 million in the 1970s and 1.7 million from 1990 through 2002.

"The trend, in magnitude, seems to be going in the right direction," Dr. Mike Bell, deputy director of the Division of Healthcare Quality Promotion at the CDC, told Reuters Health.

Despite continuing concern about hospital-acquired infections, especially ones that are resistant to antibiotics, the U.S. does not have a national system for collecting information on the problem.

The new study, led by Dr. Shelley S. Magill of the CDC and published in the New England Journal of Medicine, was based on an analysis of 11,282 patients treated at 183 hospitals in 10 states. The survey in each hospital was done over the course of a day, involving as many as 100 patients per facility.

Pneumonia accounted for about 22 percent of the hospital-acquired infections. Another 22 percent were infections at the surgical site, and 17 percent were stomach or intestinal illnesses. Urinary tract and bloodstream infections ranked fourth and fifth, respectively.

The most common bacterium responsible was Clostridium difficile, which kills an estimated 14,000 people in the U.S. each year. It was detected in 12 percent of the hospital-acquired illnesses and was responsible for 71 percent of gastrointestinal infections in particular.

Nursing homes, emergency departments, rehabilitation hospitals and outpatient treatment centers were not included in the tally.

The researchers estimated that in 2011, 648,000 hospitalized patients had to battle at least one hospital-acquired infection. The total number of infections was estimated at 721,800. To put that number in perspective, about 34 million people are admitted to 5,000 community hospitals in the U.S. each year.

The new report "validates the work we've been doing, focusing on some of the severe infections related to intensive care, related to devices such as catheters in the bloodstream or the bladder, mechanical ventilation or surgical procedures," Bell said.

To prevent infections, the National Patient Safety Foundation recommends patients wash their hands regularly and remind their doctors and nurses to do the same. Patients should also make sure both bandages and the skin around any catheters are kept clean and dry, it says.

SOURCE: http://bit.ly/1rzGOHe New England Journal of Medicine, online March 26, 2014.


View the original article here

Saturday, April 19, 2014

Exclusive: Baxter explores sale of its vaccines business - sources

By Olivia Oran and Arno Schuetze and Soyoung Kim

NEW YORK/FRANKFURT (Reuters) - Baxter International Inc is exploring a sale of its vaccines business, according to people familiar with the matter, the latest healthcare company to look at divesting non-core assets to focus on key strengths.

The medical equipment and pharmaceuticals company is working with Goldman Sachs Group to find a buyer for the unit and has reached out to potentially interested parties including private equity firms, the people said on Wednesday, asking not to be named because the matter is not public.

The Baxter unit, which includes vaccines for meningitis C and tick-borne encephalitis as well as collaborations for the development of seasonal and pandemic influenza vaccines, had 2013 sales of close to $300 million according to regulatory filings.

It could not be learned how much the business could fetch in a sale, as the deliberation is at an early stage and Baxter has yet to send out detailed financial information to potential buyers, the people added.

Representatives for Baxter did not immediately respond to requests for comment. Goldman Sachs declined to comment.

The vaccines business, which is part of Baxter's $6.5 billion BioScience segment, is profitable but the company has determined it is not core, one person said.

Deerfield, Illinois-based Baxter makes medical devices, pharmaceuticals and biotechnology products, focusing on areas including hemophilia, immune disorders and infectious diseases.

It divides its operations between the BioScience division, which makes products including plasma-based proteins to treat hemophilia, and a Medical Products division. The medical products unit makes equipment used to inject fluids and drugs and had 2013 sales of nearly $8.7 billion.

Baxter is yet another example of large healthcare companies seeking to sell or spin off smaller divisions so they can focus on their mainstay products and allocate capital better. They have shown a new willingness to consider whether other companies may be better owners for certain assets.

Novartis AG is taking a hard look at its sub-scale businesses -- animal health, vaccines and over-the-counter medicines -- for a potential divestiture, chief executive Joe Jimenez told Reuters last week, adding that at least one of the three is not expected to make the cut.

Merck & Co Inc is also in talks with several companies about selling its consumer healthcare business, a deal that could value the unit at between $10 billion and $12 billion, Reuters previously reported.

(Reporting by Olivia Oran, Soyoung Kim in New York and Arno Schuetz in Frankfurt; editing by Andrew Hay)


View the original article here

Friday, April 18, 2014

Breast Cancer Startup Challenge Inventions and Winners

The Avon Foundation for Women, in partnership with NCI and the Center for Advancing Innovation (CAI), have announced the ten winners of a world-wide competition to accelerate the process of bringing emerging breast cancer research technologies to market.

Each team was required to produce a short video explaining and highlighting their ideas.? The videos are from the winners of the Breast Cancer Startup Challenge.? This listing does not constitute NCI’s endorsement of the companies or potential products and does not guarantee a grant of license for any federally-owned technology.

Videos from the winning teams are below.

Challenge #1. Diagnostic from Biopsies with Software Analysis
Category: Diagnostics/Health IT
Lead Inventor: Tom Misteli, PhD, NCI
Winner: University of Cambridge

YouTube Preview Image

Challenge #2 -Immunotherapy Using Modified Self Tumor Cells
Category: Therapeutic
Lead Inventor: Dennis Klinman, M.D., Ph.D., NCI
Winner: Washington University in Saint Louis

YouTube Preview Image

Challenge #3 – Combination of Tissue Reconstruction and Recurrence Prevention
Category: Device/Therapeutic
Lead Inventor: Karen Burg, Ph.D., Clemson University
Winner: Tulane University
YouTube Preview Image

Finalist: Clemson University
YouTube Preview Image

Challenge #4 – Human monoclonal Antibody Based Cancer Therapies
Category: Therapeutic, Diagnostic
Lead Inventor: Mitchell Ho, Ph.D., NCI
Winner: Stanford University

YouTube Preview Image

Challenge #5 -Immunotherapy Using Granulysin Activated Monocytes
Category: Therapeutic
Lead Inventor: Alan Krensky, M.D., Northwestern University
Winner: Northwestern University

YouTube Preview Image

Challenge #6 – Anti-cancer Toxin
Category: Therapeutic
Lead Inventor: Nadya Tarasova, Ph.D., NCI
Winner: Rutgers, The State University of New Jersey

YouTube Preview Image

Challenge #7 – Versatile Delivery Method for Cancer Therapeutics
Category: Vaccine or Drug Delivery (Protein or RNA)
Lead Inventors: Stanislaw J Kaczmarczyk, Ph.D. & Deb Chatterjee, Ph.D., NCI
Winner: University of Cambridge

YouTube Preview Image

Finalist: Wake Forest University
YouTube Preview Image

Challenge #8 -Genomic Based Diagnostic Assay
Category: Diagnostics and prognostic
Lead Inventor: Steven Libutti, M.D., FACS, NCI
Winner: University of California, Berkeley

YouTube Preview Image

Challenge #9 -Tissue-based Diagnostic Assay
Category: Diagnostic
Lead Inventor: Stephen M. Hewitt, M.D., Ph.D., NCI
Winner: McGill University

YouTube Preview Image

Challenge #10 – Diagnostic Kit for Therapy Benefit Prediction
Category: Diagnostic
Lead Inventor: Sherry Yang, MD., Ph.D., NCI
Winner: Tulane University

YouTube Preview Image Print This Post?Print This Post

View the original article here

Thursday, April 17, 2014

Biologists use sound to identify breeding grounds of endangered whales

Remote acoustic monitoring among endangered whales is the subject of a major article by two doctoral students in The College of Arts and Sciences.

Leanna Matthews and Jessica McCordic, members of the Parks Lab in the Department of Biology, have co-authored "Remote Acoustic Monitoring of North Atlantic Right Whales Reveals Seasonal and Diel Variations in Acoustic Behavior." The article appears in the current issue of PLOS ONE, an inclusive, peer-reviewed, open-access resource from the Public Library of Science in San Francisco.

Susan Parks, assistant professor of biology for whom the lab is named, says the article confirms what many conservationists fear -- that Roseway Basin, a heavily traveled shipping lane, off the coast of Nova Scotia, is a vital habitat area for the endangered North Atlantic right whale.

"Remote acoustic monitoring is an important tool for understanding patterns in animal communication, and studies on the seasonality of context-specific acoustic signals allow inferences to be made about the behavior and habitat use of certain species," says Parks, an expert in behavioral ecology, acoustic communication and marine science. "Our results support the hypothesis that the North Atlantic right whale's breeding season occurs mostly from August to November and that this basin is a widely used habitat area."

More than 30 percent of all right whales use Roseway Basin, part of a larger geological formation called the Scotian Shelf, throughout the year. With only 400-500 in existence, these whales, says Parks, must congregate in the basin to feed and find mates.

Already, the U.S. and Canadian governments have taken steps to redirect shipping traffic, in response to several fatal collisions with right whales.

Matthews, whose research includes animal behavior and physiology, says the object of the article is to determine how and when Roseway Basin is used for male breeding activities.

"Part of the answer lies in a loud 'gunshot' sound, made by the male whale," says Matthews, the article's lead author. "We're not exactly sure what the gunshot is, but we think it may be a male-to-male antagonistic signal or an advertisement to females. … During a two-year period, we used non-invasive acoustic monitoring to analyze gunshots at two locations on the Scotian Shelf. The resultant data has provided tremendous insights into the whales' feeding and mating habits."

Matthews and her team found that gunshot sound production occurred mainly in the autumn and, more often than not, at night. Researchers say this kind of information is essential to not only the individual fitness of each whale, but also the survival of the species, in general.

McCordic, whose research spans animal behavior and communication, says the observed seasonal increase in gunshot sound production is consistent with the current understanding of the right whale breeding season.

"Our results demonstrate that detection of gunshots with remote acoustic monitoring can be a reliable way to track shifts in distribution and changes in acoustic behavior, including possible mating activities," she says, acknowledging David Mellinger, associate professor of marine bioacoustics at Oregon State University, who collected and provided access to the recordings used in the study. "It also provides a better understanding of right whale behavior and what needs to be done with future conservation efforts."

Parks, who assisted with the article, is proud of her students' accomplishments.

"Right whales are increasingly rare, and Leanna's and Jessica's research helps us understand how to better protect them," she says. "By identifying potential breeding areas, we might be able to save this critically endangered species."

Story Source:

The above story is based on materials provided by Syracuse University. Note: Materials may be edited for content and length.


View the original article here

Wednesday, April 16, 2014

New video-based teaching tool helps students learn animal-based lab work

For students and scientists beginning animal-based lab work, seeing a research procedure performed by experts is by far the most effective method of learning. Now the Cambridge-based company, JoVE, releases the new online video-based tool, Model Organisms II, to revolutionize the teaching of fundamental experiments in the three most common laboratory organisms -- the mouse, chick and zebrafish.

"Each of these species makes unique demands upon researchers, both in terms of the steps required for their maintenance and reproduction, as well as the tools and techniques available to study them," said Aaron Kolski-Andreaco, PhD., JoVE's Chief Product Officer, "The Model Organisms II collection provides a great overview of these nuances, in addition to providing visual demonstrations of techniques essential to working with each model."

Contrary to the traditional, text-based educational materials, Model Organisms II presents a powerful combination of scientific animation with video demonstrations by scientists from leading research institutions around the world. This novel tool is the latest installment in JoVE Science Education database dedicated to teaching laboratory fundamentals through simple, easy-to-understand visual presentations. For universities and colleges, the JoVE Science Education videos are a valuable new resource for efficient teaching and research.

"I wanted to find justification for buying it, so I sent around a message to faculty in biology," said Michael Newman, a Head Librarian and Bibliographer at Stanford University, "Those things usually don't get much response, but this time I got some pretty enthusiastic replies."

Stanford subscribed to the JoVE Science Education database in December 2013, shortly after JoVE released this database. Over 100 institutions -- including those ranging from the Ivy League to community colleges -- also purchased a subscription within only three months following the product launch.

"I've used it as a class tool where students can watch a technique on the screen and then do it immediately afterwards, and for what they're going to do the next time the class meets, so they'll come in a little less blind," said assistant professor, Dr. Jason Kuehner of Emmanuel College in Boston, MA, "For something like western blotting this is really good. That's a fairly laborious technique with multiple steps, and for students it's very easy to get confused as to what each step in the protocol means."

You can view the Science Education content at www.jove.com/se.

Story Source:

The above story is based on materials provided by Journal of Visualized Experiments (JOVE). Note: Materials may be edited for content and length.


View the original article here

Tuesday, April 15, 2014

Sensing gravity with acid: Scientists discover role for protons in neurotransmission

While probing how organisms sense gravity and acceleration, scientists at the Marine Biological Laboratory (MBL) and the University of Utah uncovered evidence that acid (proton concentration) plays a key role in communication between neurons. The surprising discovery is reported this week in the Proceedings of the National Academy of Sciences.

The team, led by the late MBL senior scientist Stephen M. Highstein, discovered that sensory cells in the inner ear continuously transmit information on orientation of the head relative to gravity and low-frequency motion to the brain using protons as the key means of synaptic signal transmission. (The synapse is the structure that allows one neuron to communicate with another by passing a chemical or electrical signal between them.)

"This addresses how we sense gravity and other low-frequency inertial stimuli, like acceleration of an automobile or roll of an airplane," says co-author Richard Rabbitt, a professor at University of Utah and adjunct faculty member in the MBL's Program in Sensory Physiology and Behavior. "These are very long-lasting signals requiring a a synapse that does not fatigue or lose sensitivity over time. Use of protons to acidify the space between cells and transmit information from one cell to another could explain how the inner ear is able to sense tonic signals, such as gravity, in a robust and energy efficient way."

The team found that this novel mode of neurotransmission between the sensory cells (type 1 vestibular hair cells) and their target afferent neurons (calyx nerve terminals), which send signals to the brain, is continuous or nonquantal. This nonquantal transmission is unusual and, for low-frequency stimuli like gravity, is more energy efficient than traditional synapses in which chemical neurotransmitters are packaged in vesicles and released quantally.

The calyx nerve terminal has a ball-in-socket shape that envelopes the sensory hair cell and helps to capture protons exiting the cell. "The inner-ear vestibular system is the only place where this particular type of synapse is present," Rabbitt says. "But the fact that protons are playing a key role here suggests they are likely to act as important signaling molecules in other synapses as well."

Previously, Erik Jorgensen of University of Utah (who recently received a Lillie Research Innovation Award from the MBL and the University of Chicago) and colleagues discovered that protons act as signaling molecules between muscle cells in the worm C. elegans and play an important role in muscle contraction. The present paper is the first to demonstrate that protons also act directly as a nonquantal chemical neurotransmitter in concert with classical neurotransmission mechanisms. The discovery suggests that similar intercellular proton signaling mechanisms might be at play in the central nervous system.

Stephen Highstein, who died in January 2014, was associate director of the MBL's Program in Sensory Physiology and Behavior. Mary Anne Mann, a research associate in the program, also participated in this research, as did Gay Holstein of Mt. Sinai School of Medicine.

Story Source:

The above story is based on materials provided by Marine Biological Laboratory. The original article was written by Diana Kenney. Note: Materials may be edited for content and length.


View the original article here